Skip to main content

Table 1 Patients’ baseline characteristics

From: Analysis of in vitro fertilization/intracytoplasmic sperm injection outcomes in infertile women with a history of thyroid cancer: a retrospective study

Characteristics

TC group

(n = 64)

Control groupa

(n = 320)

P-value

Age, mean (SD), years

33.8 (4.3)

33.6 (3.9)

0.774

Body mass index, mean (SD), kg/m2

23.1 (3.0)

23.0 (2.8)

0.688

Duration of infertility, median (IQR),y

3 (2–5)

3 (2–6)

0.531

Basal FSH, median (IQR), mIU/ml

7.1 (5.2–9.0)

6.6 (5.4–7.9)

0.237

Basal LH, median (IQR), mIU/ml

3.3 (2.4–4.2)

3.7 (2.6–5.2)

0.054

Basal estradiol, median (IQR), pmol/L

163 (126–221)

159 (128–203)

0.401

Antral follicle count in both ovaries, median (IQR)

11 (8–15)

10 (7–14)

0.398

FT4, mean (SD), ng/dl

1.5 (0.2)

1.2 (0.1)

< 0.001*

TSH, median (IQR), mIU/L

0.5 (0.2–1.2)

1.9 (1.4–2.6)

< 0.001*

  1. Abbreviations: TC thyroid cancer, IQR interquartile range, FSH follicle-stimulating hormone, LH luteinizing hormone, FT4 free thyroxine, TSH thyroid-stimulating hormone
  2. aPatients in the control group were individually matched to a single case at a ratio of 5:1 for age, body mass index, concomitant infertility factors (polycystic ovarian syndrome, endometriosis, tubal factor, or male factor), years of IVF/ICSI treatment, protocols for controlled ovarian stimulation (ultralong-term, long-term, antagonist, short-term, or mini-stimulation protocol), and ET procedures (fresh ET or frozen ET)
  3. *P < 0.05